Answers are grounded in this paper and cite their sources.
Systematic review evaluates economic outcomes of cranioplasty materials, highlighting cost implications.
Cranioplasty is an essential neurosurgical procedure for the reconstruction of skull defects following trauma, tumor resection, infection, or decompressive surgery. While advances in biomaterials and manufacturing techniques have improved clinical outcomes, the economic implications of different cranioplasty strategies remain a critical factor in decision-making. The objective of this study is to evaluate the cost-effectiveness and economic outcomes of various cranioplasty materials and techniques, including autologous bone, polymethylmethacrylate (PMMA), titanium, and polyetheretherketone. A systematic review was conducted following PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines and registered in PROSPERO (CRD420261336008). A comprehensive search of PubMed, Scopus, ScienceDirect, and Cochrane CENTRAL was performed up to March 2026. Studies reporting economic outcomes of cranioplasty procedures were included. Data were extracted independently by two reviewers, and methodological quality was assessed using the Joanna Briggs Institute critical appraisal tools. Due to heterogeneity in cost reporting and study design, a narrative synthesis was performed. Nineteen studies were included, demonstrating considerable heterogeneity in study design and economic evaluation methods. Autologous bone, while initially cost-effective, was associated with high rates of resorption (22–25%) and increased revision-related costs. Synthetic implants such as titanium and PEEK showed higher upfront costs but improved long-term cost-effectiveness due to lower complication rates. PMMA, particularly with in-house 3D-printing and locally manufactured molds, emerged as a highly economical alternative, achieving cost reductions of up to 97% while maintaining acceptable clinical outcomes. Surgical strategy also influenced costs, with immediate bone flap replacement proving more cost-effective than delayed cranioplasty. Overall study quality ranged from moderate to high. The cost-effectiveness of cranioplasty depends on balancing initial material costs with long-term outcomes. Synthetic implants may offer superior long-term value, whereas PMMA with low-cost manufacturing provides an effective solution in resource-limited settings. Individualized decision-making and standardized economic evaluations are essential to optimize outcomes.
No takes yet. Share an insight, caveat, or question.
Chouksey et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: